dc.contributor.author |
Chang, Aileen Y. |
|
dc.contributor.author |
Karwa, Rakhi |
|
dc.contributor.author |
Odhiambo, Haji |
|
dc.contributor.author |
Were, Phelix |
|
dc.contributor.author |
Fletcher, Sara L. |
|
dc.contributor.author |
Tonui, Edith C. |
|
dc.contributor.author |
Kohn, Michael A. |
|
dc.contributor.author |
Lee, Jeannette |
|
dc.contributor.author |
Chang, Di |
|
dc.contributor.author |
Lensing, Shelly |
|
dc.contributor.author |
Namaemba, Diana Flora |
|
dc.contributor.author |
Busakhala, Naftali |
|
dc.contributor.author |
Kiprono, Samson K. |
|
dc.contributor.author |
Maurer, Toby |
|
dc.contributor.author |
Goodrich, suzanne |
|
dc.contributor.author |
Pastakia, Sonak D. |
|
dc.date.accessioned |
2022-02-02T09:22:34Z |
|
dc.date.available |
2022-02-02T09:22:34Z |
|
dc.date.issued |
2022-02-02 |
|
dc.identifier.uri |
DOI https://doi.org/10.1200/GO.21.00329. |
|
dc.identifier.uri |
http://ir.mu.ac.ke:8080/jspui/handle/123456789/5914 |
|
dc.description.abstract |
bstract
PURPOSE Evaluate the effectiveness of compression while receiving chemotherapy compared with chemo therapy alone in the treatment of HIV-associated Kaposi sarcoma (KS) lymphedema.
METHODS A randomized controlled trial was conducted in a single oncology clinic in western Kenya
(NCT03404297). A computer-generated randomization schedule was used to allocate treatment arms.
Randomized block design was used for stratification by lymphedema stage. Participants were HIV positive adults
age ≥ 18 years on antiretroviral therapy with biopsy-proven KS associated with leg lymphedema and being
initiated on chemotherapy. The intervention was 10 weeks of weekly clinic-based application of two-component
paste compression bandages. The primary outcome was change in the Lower Extremity Lymphedema Index
(LELI) score from week 0 to week 14. The secondary outcomes were change in the Lymphedema Quality of Life
measure (LYMQOL) and change in the European Organisation for Research and Treatment of Cancer (EORTC)
QLQ-C30 score from week 0 to week 14. Blinded outcome assessments were conducted.
RESULTS Of 30 participants randomly assigned, 25 eligible patients (chemotherapy [control], n = 13; com pression plus chemotherapy [intervention], n = 12) returned at week 14. Change in LELI, LYMQOL, and EORTC
QLQ-C30 scores between week 14 and week 0 did not significantly differ by arm. The mean (standard deviation)
change in LELI score was –25.9 (34.6) for the control arm compared with –13.3 (29.5) for the intervention arm,
P = .340. The difference (95% CI) in the change in LELI score was –12.6 (–39.3 to 14.1).
CONCLUSION Future studies evaluating a 14-week change in LELI for KS lymphedema should assume a standard
deviation of approximately 30. Lessons learned from this pilot trial should inform the development of a larger,
multicenter trial to evaluate the effectiveness of compression for KS lymphedema |
en_US |
dc.description.sponsorship |
Toby Maurer, Sonak D. Pastakia |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
American society of clinical oncology |
en_US |
dc.subject |
Kaposi Sarcoma Leg Lymphedema |
en_US |
dc.subject |
HIV |
en_US |
dc.subject |
Chemotherapy |
en_US |
dc.title |
Compression therapy for HIV-associated Kaposi Sarcoma leg lymphedema: results of the Kenyan improvised compression for Kaposi Sarcoma randomized controlled trial |
en_US |
dc.title.alternative |
Rakhi Karwa |
en_US |
dc.type |
Article |
en_US |